This Perspective highlights the insights into the biology of BRCA1/2 afforded by mouse models and patient-derived tumor xenografts and emphasizes their value in addressing unresolved questions and preclinical evaluation of treatment strategies.
- Julia-Star Darnold
- Jos Jonkers